The book "Hepatitis B and D Protocols" offers a comprehensive analysis of the challenges and treatment options associated with chronic hepatitis B infections. Despite the availability of a vaccine, approximately 400 million people worldwide are chronically infected with the hepatitis B virus (HBV), leading to significant public health issues. Chronic infection is one of the leading causes of liver cancer, and the high mortality rate is often attributed to late diagnosis. The book highlights various therapeutic approaches, including the use of antiviral medications and immunotherapeutic strategies, to improve the treatment of HBV. It also addresses the limited effectiveness of currently available medications and emphasizes the need for further research and development. With 572 pages, this specialized book provides a detailed and well-founded resource for professionals in the fields of medicine and nursing dealing with hepatitis B and D.